Typicality: | 0.314 |
Saliency: | 0.150 |
against the cancer cells | 3 | transitive-object |
into a response | 3 | other |
vaccine → be engineered to trigger → an immune system response | 3 |
vaccine → be designed to activate → immune system | 3 |
vaccine → be designed to agitate → immune system | 3 |
negative | neutral | positive |
0.233 | 0.675 | 0.092 |
Raw frequency | 9 |
Normalized frequency | 0.150 |
Modifier score | 0.500 |
Perplexity | 27.282 |